<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM MEDIMMUNE, INC.'S QUARTERLY REPORT ON FORM 10-Q FOR THE SIX MONTHS ENDED JUNE 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FILING. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> JUN-30-1996 <CASH> 9,743 <SECURITIES> 71,324 <RECEIVABLES> 7,573 <ALLOWANCES> 0 <INVENTORY> 6,173 <CURRENT-ASSETS> 95,698 <PP&E> 10,445 <DEPRECIATION> 0 <TOTAL-ASSETS> 106,295 <CURRENT-LIABILITIES> 9,750 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 216 <OTHER-SE> 93,478 <TOTAL-LIABILITY-AND-EQUITY> 106,295 <SALES> 13,454 <TOTAL-REVENUES> 18,361 <CGS> 8,122 <TOTAL-COSTS> 28,923 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 120 <INCOME-PRETAX> (8,608) <INCOME-TAX> 0 <INCOME-CONTINUING> (8,608) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (8,608) <EPS-PRIMARY> (0.42) <EPS-DILUTED> (0.42)